[Sigsti-l] Fwd: Cell Press Announces Free Access to Recent Online Archive (fwd)

[Jon R Jablonski]

I know it's a cliche, but:  Please pardon cross posting.

To us, this is a major, major breakthrough, as Oregon has never been able
to afford any electronic access to this important set of journals.

-jon

Jon Jablonski                                                541-346-2871
Reference Librarian                                    jonjab at uoregon.edu
University of Oregon Science Library

>*Please excuse the cross-posting*
>
>The following press release was issued today from Cell Press regarding
>free access to its recent archive of journals.
>
>Daviess Menefee
>Library Relations
>Elsevier
>
>PRESS RELEASE
>Cambridge, Massachusetts, USA
>August 18, 2004
>
>Cell Press is pleased to announce that access to the recent online archive
>of Cell and the other premier journals of the Cell Press collection will
>become freely available beginning in January 2005. The recent archive of
>these journals includes content that is 12 months old or older and dating
>back to content from 1995. Each month as new issues are published, the old
>issues will be added to the freely accessible recent archive.  Free access
>to the recent archive will be available on both ScienceDirect
>(www.sciencedirect.com) and on the Cell Press journal sites
>(www.cellpress.com).
>
>Today's announcement by Cell Press represents an important change that
>will make a large part of the Cell Press journal archive freely accessible
>to the worldwide biomedical research community.  Cell Press President and
>CEO Lynne Herndon commented, "Our main goal is the dissemination of
>information and the active support of scientific exchange. In recognition
>of the opportunities afforded by electronic publishing, Cell Press is
>taking this decision in order to better meet the needs of our unique
>author and reader communities.  This opportunity also allows us to
>incorporate the notion of an open archive without adopting the
>pay-for-publication model that we believe is untested from both an
>editorial and financial perspective."
>
>Arie Jongejan, CEO Science & Technology, Elsevier added: "Cell Press
>publishes a suite of journals with a unique profile in biomedicine. Its
>readers expect science with immediate impact and its authors expect
>specialized care and extra speed. We support Cell Press' unique role in
>the life sciences and within Elsevier."
>
>Cell Press is committed to improving scientific communication through the
>publication of exciting biology research and reviews. Our mission is to
>continue to publish and develop journals that deliver the highest possible
>intellectual rigor, promote community trust, and are widely disseminated.
>To that end, we are pleased to be able to add our new policy to existing
>Elsevier initiatives:
>
>--Participation in the HINARI project of the WHO, which distributes journals
>   for free to developing countries
>   (http://www.healthinternetwork.org/index.php);
>--A liberal copyright policy that gives authors broad rights;
>--Free advance online publication of selected papers;
>--Investment in making the entire back-issue collection available online;
>--Online submission and review for the convenience of authors and reviewers;
>--Support of the research community via meeting sponsorships
>
>About Cell Press
>
>Cell Press, an imprint of Elsevier, publishes prestigious highly-cited
>biomedical research journals.  Each Cell Press journal is a leading source
>for research in its field.  The journals include Cell (www.cell.com),
>Neuron (www.neuron.org), Immunity (www.immunity.com), Molecular Cell
>(www.molecule.org), Developmental Cell (www.developmentalcell.com), Cancer
>Cell (www.cancercell.org), Current Biology (www.current-biology.com),
>Structure (www.structure.org), Chemistry & Biology (www.chembiol.com) and
>the new journal Cell Metabolism (www.cellmetabolism.org) which will launch
>in January 2005.  The Cell Metabolism recent archive will become freely
>accessible beginning in January 2006.
>
>About Elsevier
>
>Elsevier is a world-leading publisher of scientific, technical and medical
>information products and services.  Working in partnership with the global
>science and health communities, Elsevier's 6,800 employees in 86 offices
>worldwide publish more than 1,800 journals and 2,200 new books per year,
>in addition to offering a suite of innovative electronic products, such as
>ScienceDirect (http://www.sciencedirect.com/), MD Consult
>(http://www.mdconsult.com/), Scopus (http://www.news.scopus.com/),
>bibliographic databases, online reference works and subject specific
>portals.
>
>Elsevier (http://www.elsevier.com/) is a global company headquartered in
>Amsterdam, The Netherlands and has offices worldwide.  The company is part
>of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading
>publisher and information provider.  Operating in the science and medical,
>legal, education and business-to-business sectors, Reed Elsevier provides
>high-quality and flexible information solutions to users, with increasing
>emphasis on the Internet as a means of delivery.  Reed Elsevier's ticker
>symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and
>ENL (New York Stock Exchange).
>
>For more information, please contact:
>Lynne Herndon (lherndon at cell.com <mailto:lherndon at cell.com>)
>Cell Press President and CEO
>(617) 397-2815
>
>Emilie Marcus (emarcus at cell.com <mailto:emarcus at cell.com>)
>Cell Press Executive Editor and Editor of Cell
>(617) 661-7057

Emily McElroy
Collection Development & Acquisitions Librarian
University of Oregon Libraries
1299 University of Oregon
Eugene, OR 97403-1299
phone: 541-346-1646
fax: 541-346-3485
emcelroy at darkwing.uoregon.edu